Parmax Pharma shareholders and shareholding pattern
BSE: 540359Pharmaceuticals & BiotechnologySmall Cap
Last close ₹136.40down ₹1.35 (0.98%)
Share price at the BSE close on 19 Oct 2026. Previous close ₹137.75.
52-week range of traded prices to 19 Oct 2026
₹22.60Low, 25 Mar 2026₹139.10High, 5 Oct 2026
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹94 Cr4,411th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- −70.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day.
- 271
Who owns Parmax Pharma, filing by filing
Per cent of the company's shares. Every filing on record, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters64.66%
- Individuals and others35.34%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Individuals and others
| Per cent | Dec 2016Filed 25 May | Mar 2017Filed 21 Apr | Jun 2017Filed 18 Jul | Sep 2017Filed 12 Oct | Dec 2017Filed 11 Jan | Mar 2018Filed 23 Apr | Jun 2018Filed 20 Jul | Sep 2018Filed 18 Oct | Dec 2018Filed 21 Jan | Mar 2019Filed 18 Apr | Jun 2019Filed 22 Jul | Sep 2019Filed 22 Oct | Dec 2019Filed 18 Jan | Mar 2020Filed 27 Apr | Jun 2020Filed 21 Jul | Sep 2020Filed 21 Oct | Dec 2020Filed 19 Jan | Mar 2021Filed 19 Apr | Jun 2021Filed 19 Jul | Sep 2021Filed 14 Oct | Dec 2021Filed 12 Jan | Mar 2022Filed 18 Apr | Jun 2022Filed 15 Jul | Sep 2022Filed 18 Oct | Dec 2022Filed 19 Jan | Mar 2023Filed 17 Apr | Jun 2023Filed 20 Jul | Sep 2023Filed 18 Oct | Dec 2023Filed 19 Jan | Mar 2024Filed 16 Apr | Jun 2024Filed 14 Jul | Sep 2024Filed 8 Nov | Dec 2024Filed 15 Jan | Mar 2025Filed 18 Apr | Jun 2025Filed 18 Jul | Sep 2025Filed 24 Oct | Dec 2025Filed 19 Jan | Mar 2026Filed 21 Apr | Jun 2026Filed 20 Jul | Sep 2026Filed 21 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.15% | 29.15% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.83% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 64.66% | |
| Indian promoters | 29.15% | 29.15% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.83% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% | 64.66% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 70.85% | 70.85% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.17% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 69.20% | 35.34% |
| Shares in issue | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 37,41,300 | 68,78,886 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | – | 10,90,750 | 10,90,750 | 10,90,750 | 10,90,750 | 7,48,960 | 7,48,260 | 7,48,260 | 7,48,260 | 7,48,260 | 7,48,260 | 8,00,560 | 8,00,560 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2,93,520 | 48,30,136 |
| Promoters' shares locked in | – | 10,90,750 | 10,90,750 | 10,90,750 | 10,90,750 | 7,48,960 | 7,48,260 | 7,48,260 | 7,48,260 | 7,48,260 | 7,48,260 | 7,48,260 | 7,48,260 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 39,72,994 |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Parmax Pharma promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Dhiren Chandulal Shah, 15.58%.Promoter buying and selling
| Holder | ||||
|---|---|---|---|---|
| Dhiren Chandulal ShahIndividuals and Hindu undivided families | 15.58% | 10,71,428 | 4,67,238 | 100.00% |
| Abhay Chinubhai Shah.Individuals and Hindu undivided families | 8.27% | 5,68,815 | 2,46,580 | 100.00% |
| Umang Alkesh Gosalia.Individuals and Hindu undivided families | 7.89% | 5,42,466 | 2,00,000 | 100.00% |
| GOSALIA MEENA ALKESHIndividuals and Hindu undivided families | 6.90% | 4,74,800 | 4,74,800 | 0.00% |
| Hiren Pravin DoshiIndividuals and Hindu undivided families | 5.61% | 3,85,714 | 1,68,206 | 100.00% |
| Nirmal Sunilbhai ShahIndividuals and Hindu undivided families | 4.21% | 2,89,429 | 1,24,597 | 100.00% |
| Kamlesh Natvarlal Shiyani.Individuals and Hindu undivided families | 4.17% | 2,86,571 | 1,24,597 | 100.00% |
| Vijaykumar Natvarlal ShiyaniIndividuals and Hindu undivided families | 4.15% | 2,85,714 | 1,24,597 | 100.00% |
| Dhairya Dhiren ShahIndividuals and Hindu undivided families | 3.12% | 2,14,286 | 93,448 | 100.00% |
| Sunil Chinubhai ShahIndividuals and Hindu undivided families | 2.37% | 1,62,988 | 71,077 | 100.00% |
| Rupa Sunil ShahIndividuals and Hindu undivided families | 1.78% | 1,22,726 | 53,520 | 100.00% |
| Sheetal Hiren DoshiIndividuals and Hindu undivided families | 0.62% | 42,857 | 18,690 | 100.00% |
No promoter shares are reported as pledged. In demat is the part of the holding kept electronically; the rest is paper certificates. Locked in is the share of the holder's own shares that cannot be sold yet, as after a listing or an allotment.
Largest public holders of Parmax Pharma, filing by filing
Per cent, on the same shares as the split above.
| Holder | Dec 2016Filed 25 May | Mar 2017Filed 21 Apr | Jun 2017Filed 18 Jul | Sep 2017Filed 12 Oct | Dec 2017Filed 11 Jan | Mar 2018Filed 23 Apr | Jun 2018Filed 20 Jul | Sep 2018Filed 18 Oct | Dec 2018Filed 21 Jan | Mar 2019Filed 18 Apr | Jun 2019Filed 22 Jul | Sep 2019Filed 22 Oct | Dec 2019Filed 18 Jan | Mar 2020Filed 27 Apr | Jun 2020Filed 21 Jul | Sep 2020Filed 21 Oct | Dec 2020Filed 19 Jan | Mar 2021Filed 19 Apr | Jun 2021Filed 19 Jul | Sep 2021Filed 14 Oct | Dec 2021Filed 12 Jan | Mar 2022Filed 18 Apr | Jun 2022Filed 15 Jul | Sep 2022Filed 18 Oct | Dec 2022Filed 19 Jan | Mar 2023Filed 17 Apr | Jun 2023Filed 20 Jul | Sep 2023Filed 18 Oct | Dec 2023Filed 19 Jan | Mar 2024Filed 16 Apr | Jun 2024Filed 14 Jul | Sep 2024Filed 8 Nov | Dec 2024Filed 15 Jan | Mar 2025Filed 18 Apr | Jun 2025Filed 18 Jul | Sep 2025Filed 24 Oct | Dec 2025Filed 19 Jan | Mar 2026Filed 21 Apr | Jun 2026Filed 20 Jul | Sep 2026Filed 21 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Urvi Manish KothariResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.15% |
| Mili Saumil ShahResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.15% |
| Fredun Nariman Medhora.Resident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.15% |
| RAJESH JOSEPHResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.70% |
| GOSALIA NIMIT PResident individuals, over ₹2 lakh at face value | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | – | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 2.41% | 2.41% | 2.41% | 2.41% | 2.41% | 2.41% | 2.41% | 2.40% | – |
| PRADEEP RAMNIKLAL GOSALIAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 6.70% | 6.70% | 6.70% | 6.70% | 6.70% | 6.71% | 6.72% | 6.73% | 6.77% | 6.89% | 8.09% | 8.09% | 8.09% | 8.09% | 8.09% | 8.09% | 8.09% | – | – |
| VANDANA PRADEEPBHAI GOSALIAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.07% | 1.07% | 1.07% | 1.07% | 1.10% | 1.15% | – | – |
| BHARTI DEEPAK MEHTAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.54% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | – | – |
| GOSALIA VANDANA PResident individuals, over ₹2 lakh at face value | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | – | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | – | – | – | – | – | – | – | – |
| SHAH JYOTSNABEN RAMNIKLALResident individuals, over ₹2 lakh at face value | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | – | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | – | – | – | – | – | – | – | – | – |
| DHOL JAYANTIBHAI SAVJIBHAIResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% | – | – | – | – | – | – | – | – | – | – | – | – |
| ALKESH R GOSALIAResident individuals, over ₹2 lakh at face value | 6.83% | 6.81% | 6.81% | 6.81% | 6.81% | 6.81% | 6.81% | 6.81% | 6.81% | 6.81% | 6.81% | 6.81% | – | 6.81% | 6.81% | 6.81% | 6.81% | 6.81% | 6.81% | 6.81% | 6.81% | 6.81% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| GOSALIA PRADEEP RAMNIKLALResident individuals, over ₹2 lakh at face value | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | – | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | 6.68% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| KASHMIRABEN R HARDEResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | 1.46% | – | 1.46% | 1.46% | 1.46% | 1.46% | 1.46% | 1.46% | 1.46% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| ASHISH SHRIPAD KEKREResident individuals, over ₹2 lakh at face value | 1.65% | 1.65% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.